Related Experiment Videos
Primary proliferative responses to peptides of HIV Gag p24
P A Bedford1, L B Clarke, G Z Hastings
1Antigen Presentation Research Group, Imperial College School of Medicine, Northwick Park Institute for Medical Research, Harrow, England, U.K.
Insights
Researchers identified novel HIV gag T-cell epitopes using overlapping peptides. These findings could aid in developing vaccines for both HIV-negative and HIV-positive individuals, broadening immune responses.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Primary T-cell proliferative responses are crucial for initiating adaptive immunity.
- Identifying T-cell epitopes is key for developing effective vaccines against viral infections like HIV.
Purpose of the Study:
- To identify novel primary T-cell epitopes within the HIV gag p24 region.
- To assess the potential of these epitopes for vaccine development in diverse populations.
Main Methods:
- Utilized a series of 23 overlapping 15-amino acid peptides spanning the HIV gag p24 region.
- Employed 20-microliter hanging drop cultures to assess T-cell proliferation upon stimulation with antigen-pulsed dendritic cells.
- Conducted peptide-binding assays using the T2 cell line to evaluate binding to human leukocyte antigen (HLA)-A*0201.
Main Results:
- Eleven out of 23 peptides induced significant T-cell proliferative responses in healthy, HIV-negative donors.
- One peptide that bound to HLA-A*0201 also elicited a primary T-cell proliferative response.
- Identified previously unrecognized T-cell epitopes within the HIV gag protein.
Conclusions:
- Novel primary T-cell epitopes in HIV gag have been identified.
- These epitopes show promise for enhancing vaccine efficacy in antigenically naive individuals.
- The identified epitopes may broaden immune responses in individuals already infected with HIV.
Abstract:
Primary proliferative responses can be initiated by adding dendritic cells pulsed with antigen to autologous T cells in 20-microliter hanging drop cultures. To identify primary T-cell epitopes of HIV gag, a series of 23 overlapping peptides, 15 amino acids long, spanning the p24 region were used. Significant proliferative responses were induced in cells from healthy HIV-negative donors by 11 of these peptides. One of two peptides that bound human leukocyte antigen (HLA)-A *0201 in a peptide-binding assay using the antigen-processing defective cell line T2 also induced a primary proliferative response. Primary T-cell proliferation was seen in response to some peptides of gag that have not previously been identified as T-cell epitopes in cells from infected individuals. These epitopes might be useful not only for vaccines in antigenically naive individuals but also might increase the breadth of immune responses in seropositive patients.